2 withdrawn, 1 active not recruiting, 1 completed, 1 terminated. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Withdrawn 2, Active not recruiting 1, Completed 1, Terminated 1 |
Follow Gadolinium: new trials by email Literature Review of Gadolinium trials Research Report on Gadolinium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ELUDYN: Assessment of Intra-individual Variability of Vascular Dynamics of Gadopiclenol Injection Parameters in Contrast-enhanced MRI contrast agent, Gadolinium - Contrast Agent, Medical Imaging Data | Phase 4 | Active not recruiting | Hôpital Fribourgeois | 14 | 2026-01-07 | 2026-04-29 |
| Use of Gadolinium in CT Pulmonary Angiography Gadolinium - Pulmonary Embolism | Phase 4 | Withdrawn | Massachusetts General Hospital | 2017-07-01 | 2020-02-17 | |
| A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography Gadolinium - Contrast Media Allergy | Phase 4 | Withdrawn | Massachusetts General Hospital | 2016-12-01 | 2021-05-04 | |
| Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease Gadolinium - Meniere's Disease | Phase 4 | Terminated | University Hospital, Grenoble | 23 | 2016-03-16 | 2020-11-18 |
| Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction Regadenoson, Gadolinium, Cardiac MRI - Heart Transplant, Acute Graft Rejection | Phase 4 | Completed | Paul Kim | 14 | 2015-11-01 | 2017-08-22 |
Meniere Disease (1) · Pulmonary Embolism (1)
Massachusetts General Hospital (2) · Hôpital Fribourgeois (1) · Paul Kim (1) · University Hospital, Grenoble (1)
United States (3) · France (1) · Switzerland (1)
Amita Sharma, MD (1) · Paul J Kim, MD (1)
2025 (1)